SCHOLAR ROCK HOLDING CORPORATION Proceeds from (Payments for) Other Financing Activities
SCHOLAR ROCK HOLDING CORPORATION (SRRK) reported Proceeds from (Payments for) Other Financing Activities of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2026-08-06
- SCHOLAR ROCK HOLDING CORPORATION proceeds from (payments for) other financing activities for the quarter ending 2025-09-30 was $0.00.
- SCHOLAR ROCK HOLDING CORPORATION proceeds from (payments for) other financing activities for the quarter ending 2025-06-30 was $0.00.
- SCHOLAR ROCK HOLDING CORPORATION proceeds from (payments for) other financing activities for the quarter ending 2025-03-31 was $2.00K.
- SCHOLAR ROCK HOLDING CORPORATION proceeds from (payments for) other financing activities for the quarter ending 2023-12-31 was $0.00.
- SCHOLAR ROCK HOLDING CORPORATION proceeds from (payments for) other financing activities for fiscal 2023 was $3.00K.
- SCHOLAR ROCK HOLDING CORPORATION proceeds from (payments for) other financing activities for fiscal 2021 was -$20.00K.
- SCHOLAR ROCK HOLDING CORPORATION proceeds from (payments for) other financing activities for fiscal 2020 was -$19.00K.
- SCHOLAR ROCK HOLDING CORPORATION proceeds from (payments for) other financing activities for fiscal 2019 was -$13.00K.
| Period end | Proceeds from (Payments for) Other Financing Activities 3 month | Proceeds from (Payments for) Other Financing Activities 6 month | Proceeds from (Payments for) Other Financing Activities 9 month | Proceeds from (Payments for) Other Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $2.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.00K 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $2.00K 10-Q · filed 2026-05-07 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $1.00K derived: sum of 3 quarters · filed 2025-02-27 | $3.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.00K derived: sum of 2 quarters · filed 2024-11-12 | $3.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.00K 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $2.00K 10-Q · filed 2024-05-07 | |||
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$10.00K derived: sum of 2 quarters · filed 2023-03-07 | -$14.00K derived: sum of 3 quarters · filed 2023-03-07 | -$20.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$13.00K derived: sum of 2 quarters · filed 2022-11-14 | -$19.00K 10-Q · filed 2022-11-14 | -$23.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$10.00K 10-Q · filed 2022-08-08 | -$14.00K derived: sum of 3 quarters · filed 2022-08-08 | -$20.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$6.00K 10-Q · filed 2022-05-16 | -$10.00K derived: sum of 2 quarters · filed 2022-05-16 | -$16.00K derived: sum of 3 quarters · filed 2022-05-16 | -$19.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | -$10.00K derived: sum of 2 quarters · filed 2022-03-07 | -$13.00K derived: sum of 3 quarters · filed 2022-03-07 | -$19.00K 10-K · filed 2022-03-07 |
| 2020-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$9.00K derived: sum of 2 quarters · filed 2021-11-09 | -$15.00K 10-Q · filed 2021-11-09 | -$18.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$9.00K 10-Q · filed 2021-08-10 | -$12.00K derived: sum of 3 quarters · filed 2021-08-10 | -$16.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$6.00K 10-Q · filed 2021-05-13 | -$9.00K derived: sum of 2 quarters · filed 2021-05-13 | -$13.00K derived: sum of 3 quarters · filed 2021-05-13 | -$16.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$7.00K derived: sum of 2 quarters · filed 2021-03-09 | -$10.00K derived: sum of 3 quarters · filed 2021-03-09 | -$13.00K 10-K · filed 2021-03-09 |
| 2019-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$7.00K derived: sum of 2 quarters · filed 2020-11-09 | -$10.00K 10-Q · filed 2020-11-09 | -$14.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$6.00K 10-Q · filed 2020-08-07 | -$10.00K derived: sum of 3 quarters · filed 2020-08-07 | |
| 2019-03-31 | -$3.00K 10-Q · filed 2020-05-07 | -$7.00K derived: sum of 2 quarters · filed 2020-05-07 | ||
| 2018-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$6.00K 10-K · filed 2020-03-12 | ||
| 2018-09-30 | -$2.00K 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | -$8.00K 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |